bibn 99 has been researched along with Cognition Disorders in 4 studies
*Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, AR; Michael, TH; Rose, GM; Rowe, WB; Tombaugh, GC | 1 |
| Meaney, MJ; O'Donnell, JP; Pearson, D; Quirion, R; Rose, GM; Rowe, WB | 1 |
| Hamm, RJ; Pike, BR | 1 |
| Bechtel, WD; Doods, HN; Engel, W; Ensinger, HA; Entzeroth, M; Ladinsky, H; Mihm, G; Quirion, R; Rudolf, K; Schiavi, GB | 1 |
1 review(s) available for bibn 99 and Cognition Disorders
| Article | Year |
|---|---|
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology.
Topics: Animals; Benzodiazepinones; Brain; CHO Cells; Cognition Disorders; Cricetinae; Dibenzazepines; Drug Design; Motor Activity; Parasympatholytics; Piperidines; Pirenzepine; Pyridines; Rats; Receptors, Muscarinic; Structure-Activity Relationship | 1993 |
3 other study(ies) available for bibn 99 and Cognition Disorders
| Article | Year |
|---|---|
Theta-frequency synaptic potentiation in CA1 in vitro distinguishes cognitively impaired from unimpaired aged Fischer 344 rats.
Topics: Age Factors; Animals; Behavior, Animal; Cognition Disorders; Dibenzazepines; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Maze Learning; Muscarinic Antagonists; Pyridines; Rats; Rats, Inbred F344; Reaction Time; Receptor, Muscarinic M2; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Theta Rhythm | 2002 |
Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Dibenzazepines; Male; Maze Learning; Memory; Movement; Muscarinic Antagonists; Pyridines; Rats; Rats, Long-Evans; Reaction Time; Time; Time Factors | 2003 |
Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats.
Topics: Analysis of Variance; Animals; Brain Injuries; Cognition Disorders; Dibenzazepines; Drug Administration Schedule; Male; Maze Learning; Muscarinic Antagonists; Percussion; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time | 1995 |